Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

510(k) Final Decisions - June 2010

July 7, 2010 10:30 am | News | Comments

Page Last Updated: 07/07/2010 Note: If you need help accessing information in different file formats, see Instructions for Downlo

Testing Defibrillation-Proof Circuits of Medical Products Simplified

July 7, 2010 10:20 am | Compliance West USA | Product Releases | Comments

The MegaPulse Defib-5 is a simple, fast, easy-to-use tester designed to test defibrillation-proof circuits of medical products as required by the IEC. It has been updated to the requirements of IEC 60601-1:2005, EC-13, and others.

LEDs Enable Manufacture of Ultra-Thin LCDs

July 7, 2010 9:58 am | Osram Opto Semiconductors | Product Releases | Comments

Measuring just 3 × 3 × 1.6 mm, the two white versions of the OSLON LX LEDs are ideal for side injection into light guides with a thickness of 2 to 4 mm. Thanks to the optimized lens, the light

Advertisement

Sensor Provides Enhanced Range in Space-Constrained Applications

July 7, 2010 9:55 am | Optek Technology | Product Releases | Comments

Sensor Provides Enhanced Range in Space-Constrained Applications

Edge-Lit Illumination Solutions Utilize High-Efficiency LEDs

July 7, 2010 9:50 am | by Global Lighting Technologies | Global Lighting Technologies ( Glt), Inc. | Product Releases | Comments

Edge-Lit Illumination Solutions Utilize High-Efficiency LEDs

Synageva gains orphan drug status for enzyme therapy

July 7, 2010 9:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Synageva BioPharma Corp. announced today that the U.S. Food and Drug Administration has granted the company orphan drug designation for its enzyme replacement therapy in development to treat Lysosomal Acid Lipase Deficiency.

LED Driver Modules Provide High-Performance Plug-and-Play Solutions

July 7, 2010 9:36 am | by Endicott Research Group | Endicott Research Group | Product Releases | Comments

ED Driver Modules Provide High-Performance Plug-and-Play Solutions

Avnet Electronics Marketing at the Medical Design West Show

July 7, 2010 9:31 am | by BusinessWire | Videos | Comments

Video: Business Wire

TOPICS:
Advertisement

Oramed Pharmaceuticals and sanofi-aventis Enter Into an Agreement for the Insulin Supply of Oramed's Oral Insulin Capsules

July 7, 2010 8:35 am | by Bio-Medicine.Org | News | Comments

JERUSALEM, Israel , July 7, 2010 /- Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) ( http://www.oramed.com ), a developer of oral delivery systems, today announced that Oramed entered into a Manufacturing Supply Agreement (MSA) with sanofi-aventis. According to the MSA, sanofi-aventis will...

TOPICS:

Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina

July 7, 2010 8:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK , July 7 /- Reportlinker.com announces that a new market research report is available in its catalogue: Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina http://www.reportlinker.com/p0186217/Stakeholder-Opinions-Vaccines-in...

TOPICS:

Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity

July 7, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK , July 7 /- Reportlinker.com announces that a new market research report is available in its catalogue: Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity http://www.reportlinker.com/p0...

TOPICS:

Renhuang Begins Trading on NYSE Amex

July 7, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

HARBIN, China , July 7 /PRNewswire-Asia-FirstCall/ -- Renhuang Pharmaceuticals, Inc. (NYSE Amex: CBP ) ("Renhuang" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that,...

TOPICS:

Ethicon, Inc. Expands Hemostasis Product Portfolio with Approval of the Company's First Synthetic Internal Use Sealant

July 7, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

SOMERVILLE, N.J. , July 7 /- Ethicon, Inc., a worldwide leader in surgical care, announced today the introduction of ETHICON™ OMNEX™ Surgical Sealant, ETHICON™ Biosurgery's first synthetic sealant designed to achieve adjunctive hemostasis (stoppage of bleeding) in...

TOPICS:

Reprogrammed Herpes Virus Given Systemically Before Anti-vascular Drug Shrinks Distant Sarcomas

July 7, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

CINCINNATI , July 7 /PRNewswire-USNewswire/ -- Scientists have used a genetically reprogrammed herpes virus and an anti-vascular drug to shrink spreading distant sarcomas designed to model metastatic disease in mice – still an elusive goal when treating humans with cancer, according...

TOPICS:

Tecomet's Art Burghouwt shows photochemical etching capabilities in making surface texture

July 7, 2010 8:32 am | by MDTeditor | Videos | Comments

Art Burghouwt, Director of Business Development at Tecomet, shows how the company is able to provide a surface texture on orthopedic implantables using a photochemical etching process. The advantage over traditional coating processes is that this process is repeatable to fabricate the...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading